Objective

• Confirmatory research and advancement of prior biofield therapy research in cancers with the highest rate of mortality, examining the relevant biological mechanisms of action through multidimensional monitoring, rigorous treatment/sham/control conditions, dosage modulation, blockage of biofield signal, and exploratory distance therapy

Hypothesis

• Cancer cell mortality increases and proliferation decreases with biofield therapy relative to control and sham groups invitro and invivo in a way that is detectable not only through tumor remission/reduction but also by various biological markers

Projected Outcomes (In Process)

• Biofield therapy mice have higher survival rates
• Electromagnetic blocking of treatment does not prevent therapeutic effect
• Animal behavior shifts during treatment
• Change in neural correlates in therapists and mice during and after treatment
• Alteration of cancer-related epigenetic markers
• Alteration of cell signaling pathway proteins
• Altered microbiome diversity/abundance
• Immune modification, cytokines/immune cell profile
• Stem cell marker alteration
• Dosage effect is shown in audio treatment invitro
• Distance treatment invitro is effective